Skip To Main Content
Chen Rongyi on Muck Rack

Chen Rongyi

As seen in: Arthritis Research & Therapy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Chen Rongyi’s profile

Articles by Chen Rongyi

High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study | Arthritis Research & Therapy | Full Text

|
By Chen Rongyi, Ma Lingying, Ma Lili, Sun Ying, Dai Xiaojuan, Wang Jinghua, Dai Xiaomin, Chen Huiyong, Jiang Lindi
| Arthritis Research & Therapy Verified
This prospective observational study focuses on VSP in TA patients treated with tocilizumab. Although tocilizumab was effective in alleviating inflammation and disease activity, approximately 47.3% of TA patients receiving tocilizumab showed VSP during the follow-up period. This finding was consistent with those of previous reports, which did not attract enough attention (Summarized in Supplementary Table S5). Furthermore, C3 was a predictive factor for VSP, with an AUC of 0.825 in 1 year.
Open in Who Shared Issue with article?

Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension - Arthritis Research & Therapy

|
By Sun Ying, Wu Sifan, Wang Yujiao, Chen Rongyi
| Arthritis Research & Therapy Verified
Research article Open Access Published: 21 July 2021 Arthritis Research & Therapy volume 23, Article number: 196 (2021) Cite this article Abstract Background Hypertension occurred in 30–80% of Takayasu arteritis (TAK) patients around the world and the occurrence of hypertension might worsen the disease prognosis.
Open in Who Shared Issue with article?
Show More